XBiotech Inc.
Hedge Funds Holdings
Last updated:
XBiotech Inc.‘s stocks are currently a part of 20 hedge funds’ portfolios, which represents 2.83% of the total amount of its stocks outstanding. This makes up a total of 861.18K shares of XBiotech Inc.. Compared to the previous quarter, the number fell by -68.77% or -1.89M shares fewer. As for the holding position changes, 25% (5) of current hedge fund investors increased the number of shares held, 35% (7) of current holders sold a part of the shares held, and 10% (2) closed the holdings completely.
Hedge funds holding XBiotech (Q2 2018 – Q1 2023)
| Q2 2018 | 30 |
|---|---|
| Q3 2018 | 22 |
| Q4 2018 | 23 |
| Q1 2019 | 37 |
| Q2 2019 | 42 |
| Q3 2019 | 47 |
| Q4 2019 | 58 |
| Q1 2020 | 60 |
| Q2 2020 | 62 |
| Q3 2020 | 65 |
| Q4 2020 | 65 |
| Q1 2021 | 64 |
| Q2 2021 | 55 |
| Q3 2021 | 65 |
| Q4 2021 | 59 |
| Q1 2022 | 58 |
| Q2 2022 | 51 |
| Q3 2022 | 44 |
| Q4 2022 | 40 |
| Q1 2023 | 20 |
Hedge funds changes in XBiotech positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 3 | 15 | 18 | -11 |
|---|---|---|---|---|---|
| Q3 2018 | 0 | 6 | 9 | 8 | -1 |
| Q4 2018 | 7 | 3 | 5 | 6 | 2 |
| Q1 2019 | 18 | 8 | 7 | 4 | 0 |
| Q2 2019 | 17 | 12 | 10 | 12 | -9 |
| Q3 2019 | 10 | 27 | 4 | 5 | 1 |
| Q4 2019 | 17 | 25 | 12 | 6 | -2 |
| Q1 2020 | 10 | 16 | 34 | 8 | -8 |
| Q2 2020 | 16 | 23 | 16 | 14 | -7 |
| Q3 2020 | 9 | 18 | 28 | 6 | 4 |
| Q4 2020 | 7 | 18 | 22 | 7 | 11 |
| Q1 2021 | 10 | 22 | 18 | 10 | 4 |
| Q2 2021 | 2 | 18 | 25 | 11 | -1 |
| Q3 2021 | 12 | 30 | 9 | 2 | 12 |
| Q4 2021 | 10 | 22 | 13 | 16 | -2 |
| Q1 2022 | 10 | 13 | 20 | 11 | 4 |
| Q2 2022 | 13 | 16 | 17 | 19 | -14 |
| Q3 2022 | 6 | 10 | 17 | 13 | -2 |
| Q4 2022 | 2 | 6 | 18 | 6 | 8 |
| Q1 2023 | 0 | 5 | 7 | 2 | 6 |
Hedge funds changes in XBiotech stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 154,000 | 316,000 |
|---|---|---|
| Q3 2018 | 107,000 | 258,000 |
| Q4 2018 | 61,000 | 321,000 |
| Q1 2019 | 387,000 | 1,375,000 |
| Q2 2019 | 15,000 | 848,000 |
| Q3 2019 | 5,000 | 1,033,000 |
| Q4 2019 | 134,000 | 1,051,000 |
| Q1 2020 | 446,000 | 2,259,000 |
| Q2 2020 | 684,000 | 2,578,000 |
| Q3 2020 | 1,029,000 | 3,395,000 |
| Q4 2020 | 491,000 | 1,453,000 |
| Q1 2021 | 245,000 | 1,290,000 |
| Q2 2021 | 412,000 | 780,000 |
| Q3 2021 | 8,000 | 452,000 |
| Q4 2021 | 233,000 | 674,000 |
| Q1 2022 | 11,000 | 0 |
| Q2 2022 | 7,000 | 23,000 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 6,669 | 0 |
| Q1 2023 | 0 | 0 |